Bacterial capsule

Hemp Bombs® Expands Product Line of Award-Winning CBD Edibles with New Gummy Flavors, Refreshed CBD Max Chill Shot and CBD Capsules

Retrieved on: 
Friday, March 19, 2021
Drugs, Branches of biology, Health sciences, Entheogens, Euphoriants, Orphan drugs, Appetite stimulants, Aromatase inhibitors, Cannabis, Melatonin, Bacterial capsule, Hemp

The newest additions to the award-winning lineup of Hemp Bombs CBD gummies include its Immune Support CBD Gummies with 50mg of elderberry extract and 15mg of CBD in each gummy.

Key Points: 
  • The newest additions to the award-winning lineup of Hemp Bombs CBD gummies include its Immune Support CBD Gummies with 50mg of elderberry extract and 15mg of CBD in each gummy.
  • Following its "Year of More" in 2020, Hemp Bombs CBD Capsules now include more capsules per package for the same price as the previously available sizes.
  • Original CBD Capsules contain 15mg of CBD per capsule, High-Potency CBD Capsules feature 30mg of CBD per capsule and Sleep CBD Capsules contain 15mg of CBD along with 5mg of the sleep aid melatonin in each capsule.
  • Refreshed for 2021, Hemp Bombs CBD Max Chill Shot now features a new raspberry dream flavor with 100mg of CBD in a 2.5-fluid ounce bottle.

Valeo Pharma's Hesperco™ Capsules at the Core of Montreal Heart Institute's Hesperidin Coronavirus Clinical Trial

Retrieved on: 
Wednesday, February 17, 2021
MHI, Hesperidin, Bacterial capsule

(CSE:VPH) (OTCQB:VPHIF) (FSE:VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company and its Hesperco development partner, Ingenew Pharma Inc. ("Ingenew"), are pleased to announce that HespercoTM capsules, approved by Health Canada for immune support, will be at the core of the Montreal Heart Institute's ("MHI") clinical trial, "The Hesperidin Coronavirus Study".

Key Points: 
  • (CSE:VPH) (OTCQB:VPHIF) (FSE:VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company and its Hesperco development partner, Ingenew Pharma Inc. ("Ingenew"), are pleased to announce that HespercoTM capsules, approved by Health Canada for immune support, will be at the core of the Montreal Heart Institute's ("MHI") clinical trial, "The Hesperidin Coronavirus Study".
  • "The immune support properties of hesperidin, the medicinal ingredient contained in HESPERCO capsules, and its efficacy against other coronavirus strains are well documented in scientific literature.
  • Commenting on the Montreal Heart Institute's Hesperidin Coronovirus Study, Pierre Laurin, President and CEO of Ingenew, said: "We are pleased that MHI's scientists concur with our scientific findings."
  • HespercoTM capsules contain 500mg of Valeo's unique hesperidin formulation and are available in bottles of 60 capsules.

American Green (OTC:ERBB) Announces Great New CBD and Melatonin Hybrid Called Zzzzzz™

Retrieved on: 
Wednesday, July 29, 2020
Drugs, Pharmacology, Health, Circadian rhythm, Antioxidants, Melatonin, RTT, Capsule, Time capsule, Bacterial capsule

Weve named it Zzzzzzand were excited to now offer a one month supply at American Green Online this August for the first time ever!

Key Points: 
  • Weve named it Zzzzzzand were excited to now offer a one month supply at American Green Online this August for the first time ever!
  • We all know that our bodies require a good nights sleep, and in todays stress-filled world, that can be truly hard to get.
  • * Zzzzzzwill be initially offered in capsule form to provide American Greens current capsule customers with a suitable companion formula to use alongside our CBD Daytime Capsules .
  • * Each bottle of Zzzzzz contains 31 capsules and each capsule contains 50mg of Broad Spectrum CBD and 5mg of melatonin, all in organic, vegan-friendly, MCT oil for easy dosing before bedtime.

MIOPS Launches Its New Product MIOPS Capsule 360, the World's Most Versatile and Compact Motion Box Ever Created

Retrieved on: 
Tuesday, January 14, 2020
Video game consoles, Xbox 360, Capsule, Bacterial capsule

NEWARK, Del., Jan. 14, 2020 /PRNewswire-PRWeb/ --Today, MIOPS, the leading producer of creative photography equipment, including one of the most popular Camera Trigger MIOPS Smart+, launched its latest product - the MIOPS Capsule 360 - the world's most versatile and compact motion box ever created.

Key Points: 
  • NEWARK, Del., Jan. 14, 2020 /PRNewswire-PRWeb/ --Today, MIOPS, the leading producer of creative photography equipment, including one of the most popular Camera Trigger MIOPS Smart+, launched its latest product - the MIOPS Capsule 360 - the world's most versatile and compact motion box ever created.
  • MIOPS Capsule 360 is the ideal companion for filmmakers and photographers who want to go further than ever before with their projects,.
  • MIOPS Capsule 360 and its features can be used for different types of photography and videography:
    The Capsule 360 is designed to allow users to quickly create perfect motion for video clips.
  • Use your connected smartphone to teach the Capsule 360 the desired movement, and the Capsule 360 can repeat it as many times as needed.

Empty Capsules Market Worth $2.79 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, May 29, 2019
Food and drink, Foods, Articles, Excipients, Gelatin, Gels, Skin care, Bacterial capsule

The market, by type, is categorized into gelatin capsules and non-gelatin capsules.

Key Points: 
  • The market, by type, is categorized into gelatin capsules and non-gelatin capsules.
  • The non-gelatin capsules segment is expected to register highest growth in the overall Empty Capsules Market between 2016 and 2023.
  • Based on functionality, the Empty Capsules Market has been segmented into immediate-release, sustained-release, and delayed-release capsules.
  • Also, immediate-release capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.

Empty Capsules Market Worth $2.79 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, May 29, 2019
Food and drink, Foods, Articles, Excipients, Gelatin, Gels, Skin care, Bacterial capsule

The market, by type, is categorized into gelatin capsules and non-gelatin capsules.

Key Points: 
  • The market, by type, is categorized into gelatin capsules and non-gelatin capsules.
  • The non-gelatin capsules segment is expected to register highest growth in the overall Empty Capsules Market between 2016 and 2023.
  • Based on functionality, the Empty Capsules Market has been segmented into immediate-release, sustained-release, and delayed-release capsules.
  • Also, immediate-release capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.